Agreements reached under this partnership
Agreement concerning the transfer of marketing authorizations- 1
Transfer of the marketing authorizations in Japan
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
This will not affect the earnings forecast for the current fiscal year. If a long-term impact is expected depending on the future performance of the agreement, market conditions or other factors, the company will make a timely disclosure separately.
| Item | Details |
|---|---|
| Name of alliance partner | AstraZeneca K.K. |
| Alliance partner's business activities | Manufacture and marketing of the product |
| Alliance partner's location | Osaka City, Osaka Prefecture |
| Type of alliance | Agreement concerning the transfer of marketing authorizations |
| Details of the alliance | Transfer of the marketing authorizations in Japan |
| Contract Date | 25 May 2026 |
| Impact on Business Performance | This will not affect the earnings forecast for the current fiscal year. If a long-term impact is expected depending on the future performance of the agreement, market conditions or other factors, the company will make a timely disclosure separately. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Nippon Kayaku Co., Ltd. will assume responsibility for the product in order to optimize its life cycle and maintain and secure a stable, long-term supply system.